What is LBRX's additional paid-in capital?

LBRX (LBRX) reported additional paid-in capital of $527.06M in Q1 2026.

What does additional paid-in capital mean?

This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.

LBRX LBRX Additional Paid-In Capital

Additional Paid-In Capital at other companies

MapLight Therapeutics, Inc. MPLT

$821.9M—

Zevra Therapeutics, Inc.ZVRA

$602.75M+7.5%

Acadia PharmaceuticalsACAD

$3.06B+3.7%

Septerna, Inc.SEPN

$554.87M+2.8%

Rapport Therapeutics, Inc.RAPP

$727.05M+67.6%

AlkermesALKS

——

Other financials

Income statement

See full

Net income-$19.1M-259%

EPS (diluted)-$0.67+95.5%

Balance sheet

See full

Cash & equivalents$320.7M—

Total debt$3.5M—

Total equity$378.7M+481%

Total assets$393.5M—

Cash flow

See full

Operating cash flow-$23.3M-187%

CapEx$32.0K+52.4%

Free cash flow-$23.3M-186%

Valuation

See full

Market cap$888.98M+163%

Enterprise value$571.77M—

Returns & leverage

See full

Return on equity-27.9%—

Debt / equity0×—

Current ratio35.7×—

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LBRX's additional paid-in capital?: LBRX (LBRX) reported additional paid-in capital of $527.06M in Q1 2026.
What does additional paid-in capital mean?: This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.